DiscoverWSJ What’s NewsDrugmakers Face Ongoing Vaccine Hesitancy
Drugmakers Face Ongoing Vaccine Hesitancy

Drugmakers Face Ongoing Vaccine Hesitancy

Update: 2023-05-31
Share

Description

P.M. Edition for May 31. The FDA approves Pfizer’s vaccine for RSV, a deadly respiratory virus. But as Wall Street Journal health business editor Jonathan Rockoff reports, companies are preparing to introduce the shots after resistance to vaccination reached new highs during the pandemic. Annmarie Fertoli hosts.


Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Drugmakers Face Ongoing Vaccine Hesitancy

Drugmakers Face Ongoing Vaccine Hesitancy

The Wall Street Journal